MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Store in air-tight containers. Protect from light.

Provenance

This compatibility recommendation is derived from Cardicor 7.5mg tablets (Merck Serono Ltd).

Stability Notes

Store in air-tight containers. Protect from light.

Provenance

This compatibility recommendation is derived from Cardicor 7.5mg tablets (Merck Serono Ltd).

Stability Notes

Store in air-tight containers. Protect from light.

Provenance

This compatibility recommendation is derived from Cardicor 7.5mg tablets (Merck Serono Ltd).

Stability Notes

Protect from moisture. Complex administration regime makes it unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Bondronat 50mg tablets (Atnahs Pharma UK Ltd).

Stability Notes

No special precautions for storage. Monthly preparation. Complex administration regime makes it unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Bonviva 150mg tablets (Atnahs Pharma UK Ltd).

Stability Notes

No special precautions for storage. Monthly preparation. Complex administration regime makes it unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Bonviva 150mg tablets (Atnahs Pharma UK Ltd).

Stability Notes

No special precautions for storage. Monthly preparation. Complex administration regime makes it unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Bonviva 150mg tablets (Atnahs Pharma UK Ltd).

Stability Notes

Moisture sensitive medicine. Store in airtight (sealed) MCA. Protect from light. Original packaging may contain desiccant. Mixed results from stability studies but likely supports 5 weeks in sealed MCA when protected from moisture and light.

Provenance

This recommendation is based on Dispirin tablets (Reckitt Benckiser Healthcare (UK) Ltd) Aspirin 300mg and Aspirin 300mg Dispersible Tablets (Accord-UK Ltd)

Stability Notes

Store in airtight containers.

Provenance

This compatibility recommendation is derived from Nu-Seals 75 gastro-resistant tablets (Alliance Pharmaceuticals Ltd).

Stability Notes

Store in airtight containers. Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Galpseud 60mg tablets (Thornton & Ross Ltd) and Sudafed Decongestant 60mg tablets (McNeil Products Ltd).

Print this list

Medicines suitable for use in MCAs, although use is likely to be off-label.  Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed).  Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices.  Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.
There are concerns about stability and/or there is a lack of stability data available. These medicines can theoretically be used in MCAs, although use is likely to be off-label.  Mitigation measures may need to be considered.  Keep medicines in MCAs for the shortest time necessary.  Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.
Medicines under this category are not suitable for use in MCAs.
These medicines have not been reviewed by SPS.